title: Real-world challenges of treating osteoporosis.
abstract: Numerous treatments have been shown to significantly reduce the risk of osteoporosis-related fracture. Treating patients with osteoporosis therapies after an initial osteoporotic fracture can reduce the risk of future fractures 40% to 60%, resulting in significant cost reductions. But despite the availability of effective management strategies, osteoporosis management is still suboptimal. Barriers to providing quality care include knowledge, competency, and performance on the part of healthcare professionals, and knowledge and adherence to therapy on the part of patients. Addressing these barriers and treating patients appropriately can help address the potential health and economic consequences of osteoporosis.
authors: Gary Owens Associates, Glen Mills, PA, USA. gowens99@comcast.net
authors: Gary
authors: G
authors: Owens
mesh_terms: D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D019468:Disease Management; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D008019:Life Style; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D058866:Osteoporotic Fractures / Q000209:etiology / Q000517:prevention & control*; D010281:Parathyroid Hormone; D017410:Practice Guidelines as Topic; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D018570:Risk Assessment
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D010281:Parathyroid Hormone; D020849:Raloxifene Hydrochloride; D002116:Calcitonin